Turkish Thoracic Journal
Original Article

Surgical Treatment in Small-Cell Lung Cancer: Single-Center Experience and Survival


Department of Thoracic Surgery, Gaziantep University Faculty of Medicine, Gaziantep, Turkey

Turk Thorac J 2021; 22: 237-241
DOI: 10.5152/TurkThoracJ.2021.19140
Read: 103 Downloads: 11 Published: 03 June 2021

OBJECTIVE: To evaluate the clinical outcomes of patients with different stages of small-cell lung cancer (SCLC) who underwent surgical treatment.

MATERIAL AND METHODS: This retrospective study consisted of 13 patients with SCLC at a tertiary care health center. This study was conducted between 2011 and 2018 at Gaziantep University Faculty of Medicine, Thoracic Surgery Department. Patient follow-up data were collected from medical files. Patients were analyzed according to age, sex, site of resection, clinical stage, pathological stage, recurrence, operation type, chemotherapy, radiotherapy.

RESULTS: The study group consisted of 3 females and 10 males (n = 13). The mean age of the patients was 65 ± 9.3 (52-85) years. The most common location of the primary tumor was the right upper lobe (6 patients, 46.2%). The mean tumor size was 4.36 ± 2.38 cm (1-8.5). In our study, 3 patients had already metastases (2 brain and 1 had metastases in more than 2 anatomic sites). Patients with solitary metastases, who underwent lung resection and metastasis excision had similar survival according to patients without metastases.

CONCLUSION: Our results show that surgical treatment in SCLC could be contributed to the survival of patients. Therefore, patients must be given a chance for surgery, especially considering that the advances in diagnostic and surgical capabilities have increased the likelihood of early diagnosis and effective surgery.

Cite this article as: Ulusan A, Tunca İ, Şanlı M, Işık A. Surgical treatment in small-cell lung cancer: Single-center experience and survival. Turk Thorac J. 2021; 22(3): 237-241.

EISSN 2149-2530